177 related articles for article (PubMed ID: 37428911)
1. Aberrant LYZ expression in tumor cells serves as the potential biomarker and target for HCC and promotes tumor progression via csGRP78.
Gu Z; Wang L; Dong Q; Xu K; Ye J; Shao X; Yang S; Lu C; Chang C; Hou Y; Zhai Y; Wang X; He F; Sun A
Proc Natl Acad Sci U S A; 2023 Jul; 120(29):e2215744120. PubMed ID: 37428911
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.
Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y
Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107
[TBL] [Abstract][Full Text] [Related]
3. The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target.
Chen DT; Pan JH; Chen YH; Xing W; Yan Y; Yuan YF; Zeng WA
Br J Anaesth; 2019 Jun; 122(6):e157-e167. PubMed ID: 30915986
[TBL] [Abstract][Full Text] [Related]
4. IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma.
Zhang W; Liu Y; Yan Z; Yang H; Sun W; Yao Y; Chen Y; Jiang R
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581055
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
[TBL] [Abstract][Full Text] [Related]
6. NCSTN promotes hepatocellular carcinoma cell growth and metastasis via β-catenin activation in a Notch1/AKT dependent manner.
Li H; Lan T; Xu L; Liu H; Wang J; Li J; Chen X; Huang J; Li X; Yuan K; Zeng Y; Wu H
J Exp Clin Cancer Res; 2020 Jul; 39(1):128. PubMed ID: 32631394
[TBL] [Abstract][Full Text] [Related]
7. CircCAMSAP1 promotes hepatocellular carcinoma progression through miR-1294/GRAMD1A pathway.
Luo Z; Lu L; Tang Q; Wei W; Chen P; Chen Y; Pu J; Wang J
J Cell Mol Med; 2021 Apr; 25(8):3793-3802. PubMed ID: 33484498
[TBL] [Abstract][Full Text] [Related]
8. NK3 homeobox 1 (NKX3.1) up-regulates forkhead box O1 expression in hepatocellular carcinoma and thereby suppresses tumor proliferation and invasion.
Jiang J; Liu Z; Ge C; Chen C; Zhao F; Li H; Chen T; Yao M; Li J
J Biol Chem; 2017 Nov; 292(47):19146-19159. PubMed ID: 28972178
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma.
Liu Z; Wang Y; Dou C; Sun L; Li Q; Wang L; Xu Q; Yang W; Liu Q; Tu K
J Exp Clin Cancer Res; 2018 Mar; 37(1):49. PubMed ID: 29510736
[TBL] [Abstract][Full Text] [Related]
10. Cancer-associated fibroblasts promote the stemness of CD24
Li Y; Wang R; Xiong S; Wang X; Zhao Z; Bai S; Wang Y; Zhao Y; Cheng B
J Mol Med (Berl); 2019 Feb; 97(2):243-255. PubMed ID: 30564864
[TBL] [Abstract][Full Text] [Related]
11. Zinc finger protein ZBTB20 is an independent prognostic marker and promotes tumor growth of human hepatocellular carcinoma by repressing FoxO1.
Kan H; Huang Y; Li X; Liu D; Chen J; Shu M
Oncotarget; 2016 Mar; 7(12):14336-49. PubMed ID: 26893361
[TBL] [Abstract][Full Text] [Related]
12. FSTL1 Secreted by Activated Fibroblasts Promotes Hepatocellular Carcinoma Metastasis and Stemness.
Loh JJ; Li TW; Zhou L; Wong TL; Liu X; Ma VWS; Lo CM; Man K; Lee TK; Ning W; Tong M; Ma S
Cancer Res; 2021 Nov; 81(22):5692-5705. PubMed ID: 34551961
[TBL] [Abstract][Full Text] [Related]
13. Cripto-1 promotes tumor invasion and predicts poor outcomes in hepatocellular carcinoma.
Huang T; Guo YZ; Yue X; Zhang GP; Zhang Y; Kuang M; Peng BG; Li SQ
Carcinogenesis; 2020 Jul; 41(5):571-581. PubMed ID: 32649753
[TBL] [Abstract][Full Text] [Related]
14. Cripto-1 promotes tumor invasion and predicts poor outcomes in hepatocellular carcinoma.
Huang T; Guo YZ; Yue X; Zhang GP; Zhang Y; Kuang M; Peng BG; Li SQ
Carcinogenesis; 2020 Jul; 41(5):571-581. PubMed ID: 32648918
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of miR-1266-5p serves as a prognostic biomarker of hepatocellular carcinoma and facilitates tumor cell proliferation, migration and invasion.
Su Y; Xie R; Xu Q
Acta Biochim Pol; 2021 May; 68(2):293-300. PubMed ID: 34006084
[TBL] [Abstract][Full Text] [Related]
16. High expression of MAGE-A9 contributes to stemness and malignancy of human hepatocellular carcinoma.
Wei Y; Wang Y; Gong J; Rao L; Wu Z; Nie T; Shi D; Zhang L
Int J Oncol; 2018 Jan; 52(1):219-230. PubMed ID: 29138811
[TBL] [Abstract][Full Text] [Related]
17. APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is a druggable target.
Chen H; Wong CC; Liu D; Go MYY; Wu B; Peng S; Kuang M; Wong N; Yu J
Theranostics; 2019; 9(18):5246-5260. PubMed ID: 31410213
[No Abstract] [Full Text] [Related]
18. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.
Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q
J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485
[TBL] [Abstract][Full Text] [Related]
19. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
20. Dickkopf-1 Promotes Angiogenesis and is a Biomarker for Hepatic Stem Cell-like Hepatocellular Carcinoma.
Suda T; Yamashita T; Sunagozaka H; Okada H; Nio K; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Kaneko S
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
